Back to search

Article

Aptamer-enhanced immunotherapy targeting Non-Small Cell Lung Cancer cells: A conceptual approach towards T-cell mediated therapy

2026-01-06

Abstract excerpt

<title>Abstract</title> <p>Despite clinical advances with immune checkpoint inhibitors targeting the PD-1/PD-L1 axis, therapeutic response remains limited, as nearly 60% of PD-L1–positive patients fail to benefit from anti-PD-L1 monoclonal antibody therapy. Aptamers are short, single-stranded DNA or RNA oligonucleotides that selectively bind to target molecules with high affinity and specificity. Compared to mono...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
68c73e83-3ba8-5e78-9dc2-6b94541d5806
DOI
10.21203/rs.3.rs-8243965/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Aptamer-enhanced immunotherapy targeting Non-Small Cell Lung Cancer cells: A conceptual approach towards T-cell mediated therapyDOI 10.21203/rs.3.rs-8243965/v1
Select a neighboring publication to make it the new centre.